stage ivb colorectal cancer ajcc v7

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 30, 2023

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory

Active, not recruiting
  • Metastatic Colon Carcinoma
  • +24 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Corona, California
  • +7 more
Oct 26, 2022

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in

Recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Canada,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Durvalumab
  • +2 more
  • Phoenix, Arizona
  • +41 more
Jul 16, 2022

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,

Active, not recruiting
  • Colon Adenocarcinoma
  • +8 more
  • Clobetasol Propionate
  • +3 more
  • Phoenix, Arizona
  • +21 more
Jan 5, 2022

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022

Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,

Terminated
  • Colorectal Adenocarcinoma
  • +12 more
  • Adoptive Immunotherapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 28, 2020

Colorectal Adenocarcinoma, RAS Wild Type, Stage III Colorectal Cancer AJCC v7 Trial in Los Angeles (biological, drug, other)

Terminated
  • Colorectal Adenocarcinoma
  • +8 more
  • Panitumumab
  • +6 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jun 8, 2020